Inflammatory Markers and Their Relationship to Heart Rate Variability
Key Inflammatory Mediators
- Tumor necrosis factor‑α (TNF‑α) is identified as a central inflammatory marker in the pathophysiology of cardiovascular disease – evidence from basic and clinical research published in Brain, Behavior, and Immunity (2023) supports its mechanistic relevance. 1
Factors That Influence Both HRV and Inflammatory Biomarkers
- A broad set of contemporaneous variables simultaneously affect heart‑rate variability and inflammatory markers, including environmental pollution, acute and chronic psychosocial stress, body‑mass index, physical activity level, smoking status, depressive symptoms, and various medications. These confounders were highlighted in a 2023 review in Brain, Behavior, and Immunity. 1
Temporal Stability of Inflammatory Markers
| Time Interval | Correlation Coefficient (r) | Interpretation |
|---|---|---|
| < 6 months | 0.80 – 0.61 | Strong to moderate stability |
| 6 months – 3 years | 0.60 – 0.51 | Moderate stability |
| > 3 years | 0.39 – 0.30 | Low stability |
These stability estimates were reported in two 2023 articles in Brain, Behavior, and Immunity*, indicating that repeat measurements are needed for long‑term risk assessment. [4][5]
Impact of Repeated Inflammatory Measurements on Cardiovascular Risk Prediction
- Accounting for year‑to‑year variation in interleukin‑6 (IL‑6) improves coronary heart disease (CHD) risk prediction by approximately 50 % over a 12‑year follow‑up, demonstrating that single‑time‑point assessments may substantially underestimate risk. This finding derives from longitudinal analyses published in Brain, Behavior, and Immunity (2023). [2][6]